unknown
Stage
About
Adjuvance develops a semi-synthetic process to mass-produce a superior version of the QS21 vaccine adjuvant, aiming to enhance vaccine efficacy where current solutions are suboptimal.
Explore Adjuvance's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.